Jesse Helen E, Nye Tacita L, McLean Samantha, Green Jeffrey, Mann Brian E, Poole Robert K
Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.
Biochim Biophys Acta. 2013 Sep;1834(9):1693-703. doi: 10.1016/j.bbapap.2013.04.019. Epub 2013 Apr 26.
CO-releasing molecules (CO-RMs) are potential therapeutic agents, able to deliver CO - a critical gasotransmitter - in biological environments. CO-RMs are also effective antimicrobial agents; although the mechanisms of action are poorly defined, haem-containing terminal oxidases are primary targets. Nevertheless, it is clear from several studies that the effects of CO-RMs on biological systems are frequently not adequately explained by the release of CO: CO-RMs are generally more potent inhibitors than is CO gas and other effects of the molecules are evident.
Because sensitivity to CO-RMs cannot be predicted by sensitivity to CO gas, we assess the differential susceptibilities of strains, each expressing only one of the three terminal oxidases of E. coli - cytochrome bd-I, cytochrome bd-II and cytochrome bo', to inhibition by CORM-3. We present the first sensitive measurement of the oxygen affinity of cytochrome bd-II (Km 0.24μM) employing globin deoxygenation. Finally, we investigate the way(s) in which thiol compounds abolish the inhibitory effects of CORM-2 and CORM-3 on respiration, growth and viability, a phenomenon that is well documented, but poorly understood.
We show that a strain expressing cytochrome bd-I as the sole oxidase is least susceptible to inhibition by CORM-3 in its growth and respiration of both intact cells and membranes. Growth studies show that cytochrome bd-II has similar CORM-3 sensitivity to cytochrome bo'. Cytochromes bo' and bd-II also have considerably lower affinities for oxygen than bd-I. We show that the ability of N-acetylcysteine to abrogate the toxic effects of CO-RMs is not attributable to its antioxidant effects, or prevention of CO targeting to the oxidases, but may be largely due to the inhibition of CO-RM uptake by bacterial cells.
A strain expressing cytochrome bd-I as the sole terminal oxidase is least susceptible to inhibition by CORM-3. N-acetylcysteine is a potent inhibitor of CO-RM uptake by E. coli.
Rational design and exploitation of CO-RMs require a fundamental understanding of their activity. CO and CO-RMs have multifaceted effects on mammalian and microbial cells; here we show that the quinol oxidases of E. coli are differentially sensitive to CORM-3. This article is part of a Special Issue entitled: Oxygen Binding and Sensing Proteins.
一氧化碳释放分子(CO-RMs)是潜在的治疗剂,能够在生物环境中释放一氧化碳——一种关键的气体信号分子。CO-RMs也是有效的抗菌剂;尽管其作用机制尚不清楚,但含血红素的末端氧化酶是主要靶点。然而,多项研究表明,CO-RMs对生物系统的影响通常不能仅通过一氧化碳的释放来充分解释:CO-RMs通常比一氧化碳气体更具抑制活性,且分子的其他效应也很明显。
由于对CO-RMs的敏感性无法通过对一氧化碳气体的敏感性来预测,我们评估了分别仅表达大肠杆菌三种末端氧化酶之一——细胞色素bd-I、细胞色素bd-II和细胞色素bo'的菌株对CORM-3抑制作用的不同敏感性。我们首次采用珠蛋白脱氧法灵敏地测定了细胞色素bd-II的氧亲和力(Km为0.24μM)。最后,我们研究了硫醇化合物消除CORM-2和CORM-3对呼吸、生长和活力抑制作用的方式,这一现象已有充分记录,但了解甚少。
我们发现,仅表达细胞色素bd-I作为唯一氧化酶的菌株在完整细胞和细胞膜的生长及呼吸过程中对CORM-3的抑制最不敏感。生长研究表明,细胞色素bd-II对CORM-3的敏感性与细胞色素bo'相似。细胞色素bo'和bd-II对氧的亲和力也比bd-I低得多。我们表明,N-乙酰半胱氨酸消除CO-RMs毒性作用的能力并非归因于其抗氧化作用或防止一氧化碳靶向氧化酶,而可能主要是由于抑制了细菌细胞对CO-RM的摄取。
仅表达细胞色素bd-I作为唯一末端氧化酶的菌株对CORM-3的抑制最不敏感。N-乙酰半胱氨酸是大肠杆菌摄取CO-RM的有效抑制剂。
合理设计和利用CO-RMs需要对其活性有基本的了解。一氧化碳和CO-RMs对哺乳动物和微生物细胞有多方面的影响;在这里我们表明,大肠杆菌的喹啉氧化酶对CORM-3的敏感性不同。本文是名为:氧结合与传感蛋白的特刊的一部分。